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Stepwise phosphorylation of p65 promotes NF-kB
activation and NK cell responses during target cell
recognition
Hyung-Joon Kwon1, Go-Eun Choi1,2, Sangryeol Ryu3, Soon Jae Kwon1, Sun Chang Kim4, Claire Booth5,
Kim E. Nichols6 & Hun Sik Kim1,7,8
NF-kB is a key transcription factor that dictates the outcome of diverse immune responses.
How NF-kB is regulated by multiple activating receptors that are engaged during natural killer
(NK)-target cell contact remains undeﬁned. Here we show that sole engagement of NKG2D,
2B4 or DNAM-1 is insufﬁcient for NF-kB activation. Rather, cooperation between these
receptors is required at the level of Vav1 for synergistic NF-kB activation. Vav1-dependent
synergistic signalling requires a separate PI3K-Akt signal, primarily mediated by NKG2D or
DNAM-1, for optimal p65 phosphorylation and NF-kB activation. Vav1 controls downstream
p65 phosphorylation and NF-kB activation. Synergistic signalling is defective in X-linked
lymphoproliferative disease (XLP1) NK cells entailing 2B4 dysfunction and required for
p65 phosphorylation by PI3K-Akt signal, suggesting stepwise signalling checkpoint for
NF-kB activation. Thus, our study provides a framework explaining how signals from
different activating receptors are coordinated to determine speciﬁcity and magnitude of
NF-kB activation and NK cell responses.
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N
atural killer (NK) cells serve pivotal roles in the early
defence against transformed and virus-infected cells and
also help shape adaptive immune responses by regulating
antigen-presenting cells and T-cell responses1,2. These effector
functions involve the secretion of cytokines such as Interferon-g
(IFN-g) and tumor-necrosis factor-a (TNF-a) and the contact-
dependent cytolysis of target cells3. NK cells can mount
selective responses against diseased cells via integration of
signals delivered by an array of germ line-encoded receptors1.
To avoid inappropriate NK cell reactivity towards healthy
cells, signals from multiple activating receptors are kept in check
by inhibitory receptors such as killer cell Ig-like receptors and
CD94-NKG2A heterodimer speciﬁc for MHC class I molecules on
target cells. Even in the absence of such inhibition, engagement
of a single activating receptor is generally insufﬁcient to
activate resting human NK cells because of a cell-intrinsic
inhibition mechanism4. Efﬁcient activation of resting
NK cells requires combined stimulation by particular pairs of
coactivation receptors, which function in combination (hereafter
referred to as ‘synergistic’ signalling). This differs from the
activation of cytokine-stimulated NK cells, which no longer
require coactivation5,6.
Receptor combinations that function synergistically include
2B4 (CD244) paired with NKG2D (CD314) or DNAM-1
(CD226), each with its unique signalling properties. 2B4 carries
an ITSM motif in its cytoplasmic tail and transmits activation
signals through recruitment of the small adaptor SAP and
SAP-associated tyrosine kinase Fyn7,8. 2B4 signalling leads to
Vav1, p38 MAPK, Erk and PLC-g2 activation9. Notably, in NK
cells from patients with the inherited immunodeﬁciency
X-linked lymphoproliferative disease (XLP1), which lack
functional SAP expression, 2B4 fails to activate and may
instead deliver inhibitory signals10. NKG2D associates with the
adaptor DAP10, which carries a YINM motif and signals through
recruitment of phosphatidylinositol-3-kinase (PI3K) or
Grb2-Vav1 complex11. NKG2D signalling involves Akt and
MAPK Erk and Jnk. DNAM-1 signalling in NK cells remains
unclear. DNAM-1 is associated with Fyn and phosphorylated by
protein kinase C12, which is required for optimal differentiation
of memory NK cells during cytomegalovirus infection13.
NK cell activation through receptors for ligands present on
target cells can stimulate early cytokine and chemokine
production, as well as target cell killing. A recent study on
distinct NK subsets revealed CD56dim NK cells, which are
regarded as being specialized in cytotoxicity, to be a prominent
source of cytokines upon contact with target cells14. Such
cytokine responses, together with cytolytic activity, may
constitute an important component of early immune
surveillance. Although NK cell responses to soluble factors
have been extensively studied (for example, IFN-g production
by interleukin (IL)-12 and IL-18) (ref. 15), the molecular
mechanisms that control cytokine and chemokine production
during NK-target cell contact remain largely undeﬁned.
Signalling by various surface receptors modulates the activity of
diverse transcription factors, which in turn induce the
reprogramming of gene transcription for cytokine and chemokine
production. A key transcription factor for such regulation is
nuclear factor-kB (NF-kB)16,17. NK cells from patients deﬁcient
for NF-kB components, such as NF-kB essential modulator
(NEMO) and inhibitor of kB (IkB) kinase b (IKKb), demonstrate
severe defects in IFN-g production and cytotoxic function upon
target cell recognition18,19, thus revealing the pivotal role of
NF-kB in NK cell effector functions via receptor stimulation. The
signalling pathways leading to NF-kB activation in NK cells have
been characterized to some extent, but such studies are mostly
conﬁned to a few NK cell-activating receptors associated with
immunoreceptor tyrosine-based activation motif (ITAM)-bearing
adaptor molecules such as DAP12, FcRg and CD3z (refs 20,21).
These include NKp30 in humans and NK1.1, Ly49D, Ly49H,
CD16 and NKG2D in mice. Unlike human NKG2D, murine
NKG2D can associate with both DAP12 and DAP10 (refs 22,23).
The signalling pathways downstream of ITAM-coupled receptors
in NK cells are considered similar to those triggered by the
antigen-speciﬁc receptors on B and T cells9. In contrast,
it remains unclear how the signalling cascades induced by
non-ITAM-associated receptors (for example, NKG2D, 2B4,
DNAM-1) are coupled to NF-kB activation. Furthermore,
because of multiple receptor–ligand interactions that occur
during NK-target cell contact, it is important to understand
how signals from different NK cell receptors are coordinated to
control NF-kB activation.
Based on the requirement for cooperation among coactivation
receptors to trigger effective cytokine production by resting NK
cells, signalling by a single coactivation receptor may not sufﬁce
to activate NF-kB. Instead, it may require integration of disparate
signals from coactivation receptors for proper NF-kB activation.
In this study, we reveal that cooperative engagement of 2B4 with
NKG2D or DNAM-1 is required to achieve signalling
competence for full NF-kB activation. Furthermore, we uncover
an unexpected checkpoint in NF-kB activation by revealing
a requirement for complementary signals to converge at the
level of Vav1 and downstream NF-kB p65 subunit. The
pathophysiological relevance of this ﬁnding is supported by
our identiﬁcation of defective synergistic NF-kB activation and
NK cell responses centred on Vav1 in XLP1 NK cells, which lack
functional SAP, a signalling molecule required for 2B4-mediated
signalling.
Results
Synergistic activation of NF-jB by NKG2D and 2B4. Various
stimulatory receptors trigger distinct signalling pathways that
lead to NF-kB activation24. Such diverse NF-kB-activating
stimuli, however, frequently converge on the IKK complex,
and signalling cascade downstream of IKK appears to be
well-conserved among most NF-kB activation pathways. This
includes the phosphorylation and degradation of the IkB family,
which releases bound NF-kB dimers for nuclear translocation and
target gene transcription. So far, little is known about the
mechanisms that couple non-ITAM-associated receptors to
NF-kB activation during the triggering of natural cytotoxicity
by NK cells. Thus, we ﬁrst assessed NF-kB activation after
stimulating NK cells via NKG2D, 2B4 or both. Stimulation of
human NK cell line NKL with NKG2D or 2B4 alone resulted in
detectable but weak phosphorylation of IKK and Erk, whereas
co-engagement led to their synergistic phosphorylation (Fig. 1a).
Such an increase was distinct from Akt phosphorylation, which is
downstream of PI3K activation via NKG2D but not 2B4 (Fig. 1a).
Likewise, phosphorylation of the downstream NF-kB p65
subunit (pS536-p65) resembled that of IKK. Such synergistic
phosphorylation was evident at 5min and decreased thereafter,
which coincided with the phosphorylation and degradation of
IkBa that links IKK activation and p65 nuclear translocation
(Fig. 1b). We next performed microscopy experiments to
assess nuclear translocation of p65 in individual NKL-target cell
conjugates. To facilitate NKL cell identiﬁcation, they were labelled
with carboxyﬂuorescein succinimidyl ester (CFSE) and conju-
gated with unlabelled P815 target cells. In conjugated NKL cells,
little or weak nuclear translocation of p65 was observed after
stimulation with NKG2D or 2B4 alone (Fig. 1c). In contrast,
signiﬁcant nuclear translocation of p65 was detected in conju-
gated NKL cells following NKG2D and 2B4 co-engagement
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Figure 1 | Synergistic activation of NF-jB by NKG2D and 2B4 co-engagement. (a) NKL cells rested in the absence of IL-2 for 24 h were stimulated with
NKG2D and/or 2B4 by receptor crosslinking for the indicated time. Cell lysates were immunoblotted with Abs to phospho-p65 at serine 536 (pS536), p65,
phospho-IKKa/b at serine 176/180 (pS176/180), IKKb, phospho-Akt at serine 473 (pS473), phospho-Erk1 and 2, or actin. The normalized intensities of the
phosphorylated p65 and IKKa/b relative to their total forms are presented. (b) Rested NKL cells were treated as in a to stimulate NKG2D and 2B4 for the
indicated time. Lysates were immunoblotted for phospho-p65, phospho-IKKa/b, phospho-IkBa at serine 32/36 (pS32/36), IkBa, phospho-Erk1/2 or actin.
(c) Representative confocal images (top) of conjugates between rested NKL cells loaded with CFSE (green) and P815 target cells as indicated. Conjugates
were ﬁxed, permeabilized and stained with 4,6-diamidino-2-phenylindole (DAPI; blue) and mAb to p65, anti-mouse IgG-Biotin followed with Alexa Fluor
647 (red)-Streptavidin. The number beneath the overlay image is the mean nuclear ﬂuorescence intensity (MFI)±s.d. of p65 from Z50 NKL-target cell
conjugates. Statistical bar charts (bottom) for MFI of p65 in the nucleus are represented as fold change. Values represent mean±s.d. Scale bar, 5 mm.
(d) Rested NKL cells were stimulated with plate-immobilized mAbs to NKG2D and/or 2B4 for 1 h. Equal amounts of protein from cytoplasmic and nuclear
extracts were immunoblotted with mAb to p65. (e) Nuclear extracts collected as in d were added into a 96-well plate immobilized with double-stranded
oligonucleotide containing the consensus NF-kB-binding sequence. The amount of p65 bound to the oligonucleotide was measured by colorimetric assay.
Values represent mean±s.d. (f) Rested NKL cells transduced with a kB-GFP reporter construct were stimulated with plate-immobilized mAbs to NKG2D
and/or 2B4 for 6 h. GFP expression in NKL-kB-GFP cells was analysed by ﬂow cytometry, and representative result (top) and statistical bar charts (bottom)
are shown. Values represent mean±s.d. Po0.05; **Po0.01; ***Po0.001 (two-sided Student’s t-test). Data are representative of at least three
independent experiments.
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(Fig. 1c). Supporting this, analysis of subcellular fractions revealed
a substantial increase in nuclear p65 and concomitant decrease in
cytoplasmic p65 in NKL cells stimulated with NKG2D and 2B4
but neither receptor alone (Fig. 1d). Further, the amount of p65
bound to oligonucleotide containing consensus NF-kB-binding
site was signiﬁcantly increased in the nuclear extracts of NKL cells
following NKG2D and 2B4 co-engagement (Fig. 1e). Finally, to
evaluate the transcriptional activity of NF-kB, we generated NKL
reporter (NKL-kB-GFP) cells that express GFP under the control
of NF-kB transcription response elements. Proper functioning of
the reporter cells was demonstrated by increased GFP expression
following TNF-a treatment and its abrogation by prior treatment
with BAY11-7082 that inhibits NF-kB activation (Supplementary
Fig. 1). Compared with either receptor alone, NKG2D and 2B4
co-engagement induced an apparent and synergistic increase
in the proportion of cells expressing GFP (Fig. 1f). Thus, via
comprehensive analyses of conserved steps in the NF-kB
activation pathway, we conclude that robust NF-kB activation
is not achieved by stimulation with NKG2D or 2B4 alone, but
instead relies on the integration of distinct signals from NKG2D
and 2B4.
NF-jB is required for NK cell functions by NKG2D and 2B4.
Given NF-kB as a transcription factor important for gene
regulation, we assessed gene expression after stimulating NK
cells with NKG2D, 2B4 or both. Examination of a proﬁle of 20
genes encompassing cytokines, chemokines, cytolytic pathway,
death receptor pathway, NF-kB pathway, apoptosis, IL-2
receptor and cytotoxic granule exocytosis revealed a synergistic
induction of diverse genes related to NK cell effector functions
(Supplementary Fig. 2), correlating with the increase in NF-kB
activation. Chemokine expression appears to be preferentially
triggered by engagement of a single receptor (especially NKG2D),
corroborating a recent study of the requirement for less
stimulation to induce chemokine production compared with
cytokine production or degranulation14. Nonetheless, NKG2D
and 2B4 co-engagement still induced higher levels of chemokine
and cytokine gene expression.
Among the major genes induced by NF-kB are those encoding
cytokines and chemokines. The synergy-dependent activation of
NF-kB (Fig. 1) and mRNA expression of IFN-g and MIP-1a
(Supplementary Fig. 2) prompted us to test whether NF-kB is
required for NK cells to produce cytokines and chemokines
following NKG2D and 2B4 engagement. The synergistic
production of IFN-g and MIP-1a by NKL cells was diminished
in a dose-dependent manner following BAY11-7082 treatment
(Fig. 2a). To directly probe the role of NF-kB, we silenced the
expression of NF-kB p65 subunit, using small interfering RNA
(siRNA) (Fig. 2b). p65 knockdown caused marked reductions in
mRNA expression of IFN-g, TNF-a, MIP-1a/b, granzyme B and
IkBa induced by NKG2D and 2B4 co-engagement (Fig. 2c),
conﬁrming the dependence of their transcription on NF-kB.
Similarly, the synergistic production of IFN-g and MIP-1a was
signiﬁcantly reduced by p65 knockdown (Fig. 2d). To conﬁrm
this ﬁnding in the context of physiological receptor–ligand
interactions, we stimulated NKL cells with P815 cells expressing
ULBP1 (a ligand for NKG2D) and/or CD48 (a ligand for 2B4).
Consistently, synergistic production of IFN-g and MIP-1a
following physiological stimulation was signiﬁcantly diminished
by p65 knockdown (Supplementary Fig. 3).
Given the reports showing defective cytotoxicity of NK cells
from patients with NF-kB deﬁciency18,19, we next assessed
whether NF-kB is also required for cytotoxic degranulation of
NK cells. The synergistic increase in degranulation, as assessed
by granzyme B release, was signiﬁcantly decreased by p65
knockdown (Fig. 2e). Collectively, NF-kB could play an
indispensable role in the production of cytokines and
chemokines, as well as the release of granzyme B by NK cells
via non-ITAM-associated receptors NKG2D and 2B4.
We next determined whether the ﬁndings obtained from NKL
cells were applicable to primary NK cells. NF-kB activation was
assessed using puriﬁed NK cells on a per-cell basis by ﬂow
cytometry-based analysis of p65 phosphorylation. Similar to
experiments using NKL cells (Supplementary Fig. 4), the
proportion of responding cells synergistically increased following
combined stimulation of primary NK cells with NKG2D and
2B4 (Supplementary Fig. 5a). NKG2D and 2B4 co-engagement
also led to synergistic increase in the proportion of NK
cells expressing IFN-g or TNF-a (Supplementary Fig. 5b), which
was diminished after BAY11-7082 treatment (Supplementary
Fig. 5c). BAY11-7082 did not signiﬁcantly affect the viability of
NKL cells and primary NK cells, as assessed by annexin-V/PI
staining (Supplementary Fig. 6). Collectively, these results suggest
that NKG2D and 2B4 coactivation is required to overcome a
threshold for NF-kB activation, leading to synergistic cytokine
production by NK cells.
Disparate signals converge on the NF-jB p65 subunit. NF-kB
activation occurs primarily via IKK-dependent phosphorylation
and degradation of IkB proteins, followed by nuclear
translocation of the released NF-kB dimers. In addition, optimal
NF-kB activation relies on post-translational modiﬁcations of
NF-kB subunits, such as p65 phosphorylation, by speciﬁc protein
kinases25,26. These emerging and additional layers of NF-kB
regulation represent an important means for crosstalk between
different signalling pathways and determining context-speciﬁc
transcriptional responses27. NKG2D and 2B4 co-engagement
induces two distinct pathways that lead to the activation of
PI3K-Akt and Vav1-dependent synergistic signalling involving
PLC-g2 and Erk4. Given the site-selective phosphorylation of p65
through Akt and Erk pathways26, Vav1-dependent synergy
achieved by a proximal convergence of signals from
coactivation receptors may not sufﬁce to activate NF-kB.
Although stimulation of NKL cells with NKG2D or 2B4 alone
induced weak p65 phosphorylation at serine 276 and 536,
NKG2D and 2B4 co-engagement functioned synergistically to
increase their phosphorylation (Fig. 3a). In support, synergistic
phosphorylation of p65 was observed after stimulation with P815
cells expressing ULBP1 and CD48 (Supplementary Fig. 7).
To assess the dependence of such phosphorylation on Akt
and Erk pathways, NKL cells were treated with an inhibitor of
PI3K (LY294002) or MEK (PD98059), which block Akt or Erk
activation, respectively. Notably, p65 phosphorylation at serine
276 fully depended on NKG2D and 2B4 co-engagement-induced
Erk activation (Fig. 3b). In contrast, p65 phosphorylation at
serine 536 largely depended on NKG2D-induced PI3K-Akt.
The PI3K-Akt and synergistic Erk pathway appear to be mutually
independent, given the insensitivity of synergistic Erk activation
to PI3K inhibitors and Akt activation to MEK inhibitors4.
The functional signiﬁcance of these pathways was supported by
signiﬁcant impairment of IFN-g and MIP-1a production by an
inhibitor of each pathway and further by the combined inhibition
of both pathways (Fig. 3c). To probe the direct role of these
kinase pathways, we performed knockdown of Akt1 and/or Erk2
in NKL cells. Both Akt1 and Erk2 were required for optimal p65
phosphorylation and IFN-g and MIP-1a production following
coactivation, complementing the results with small-molecule
inhibitors (Supplementary Fig. 8).
We next assessed these ﬁndings using primary rested human
NK cells. Similar to the results seen in NKL cells, NKG2D and 2B4
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co-engagement led to synergistic phosphorylation of p65 at serine
276 and 536 (Fig. 3d). Moreover, we observed that phosphoryla-
tion of S276-p65 was selectively dependent on Erk pathway,
whereas phosphorylation of S536-p65 largely relied on
Akt(Fig. 3e). As expected, synergistic expression of IFN-g and
TNF-a was diminished by inhibiting Akt, Erk or both pathways
(Fig. 3f), correlating with reduced NF-kB activation, as determined
using reporter cells (NKL-kB-GFP; Fig. 3g). The combined
inhibition of Akt and Erk pathways demonstrated an additive
effect on dampening NF-kB activation, suggesting separate
involvement of Akt and Erk pathways in NF-kB activation.
To determine whether p65 phosphorylation is similarly
induced by a different combination of coactivation receptors,
primary NK cells were examined after engaging DNAM-1, 2B4 or
both. DNAM-1 synergizes with 2B4 to trigger effector
functions28. Notably, crosslinking DNAM-1 induced Akt
phosphorylation, as did NKG2D, and 2B4 co-engagement
induced a synergistic phosphorylation of Erk, an apparent dual
phosphorylation of p65, and synergistic NF-kB activation
(Supplementary Fig. 9a,b). These suggest that the basis for
NF-kB activation is shared between DNAM-1 and NKG2D. In
contrast, crosslinking CD16, which mediates antibody-dependent
cellular cytotoxicity and is sufﬁcient for cytokine production,
induced dual phosphorylation of p65 in addition to Akt and Erk
phosphorylation (Fig. 3d). These suggest distinct regulation of
p65 phosphorylation by coactivation receptors for natural
cytotoxicity that are incapable of activating alone. Thus,
co-engagement of 2B4 with NKG2D, or DNAM-1, was required
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to achieve signalling competence for p65 phosphorylation and
NF-kB activation.
Signal ampliﬁcation is insufﬁcient for NF-jB activation. The
dependence of NK cell activation on synergistic signals is, in
part, relieved after c-Cbl knockdown4. Thus, we examined
whether depleting c-Cbl enables NKG2D or 2B4 to bypass the
requirement for synergistic signals to induce p65 phosphorylation
and NF-kB activation. c-Cbl knockdown slightly enhanced p65
phosphorylation at serine 536 and 276 in response to NKG2D or
2B4 alone (Fig. 4a). However, it remained lower than p65
phosphorylation by their synergistic coactivation. In contrast,
c-Cbl knockdown substantially enhanced p65 phosphorylation at
both serines following synergistic coactivation.
Given the role of Akt and Erk in the phosphorylation of S536-
p65 and S276-p65, we next assessed the effects of c-Cbl
knockdown on Akt and Erk phosphorylation. Although Akt
phosphorylation induced by NKG2D was markedly augmented
by c-Cbl knockdown, it was undetectable following 2B4
stimulation even after c-Cbl knockdown (Fig. 4a). In comparison,
c-Cbl knockdown caused a small increase in Erk phosphorylation
by NKG2D or 2B4 alone, but an apparent increase by their
synergistic coactivation. These results suggest that c-Cbl knock-
down may amplify signal input, but not trigger disparate signals
for NF-kB activation.
The extent of pS276-p65 induced by NKG2D, 2B4 or both
correlated with the level of Erk phosphorylation (Fig. 4a). In
contrast, the correlation between pS536-p65 and Akt phosphor-
ylation was observed following NKG2D and 2B4 coactivation, but
not NKG2D alone, although there was comparable Akt phosphor-
ylation. This suggests a checkpoint that restrains pS536-p65 by Akt
pathway, which could be overcome by synergistic coactivation. In
support, NF-kB activation and production of IFN-g and MIP-1a
by NKG2D and 2B4 coactivation but not by a single receptor was
markedly enhanced after c-Cbl knockdown (Fig. 4b,c). Together,
signal ampliﬁcation from individual receptor could not
compensate for the lack of complementary signals from its partner
receptor for NF-kB activation.
Defective NF-jB activation in XLP1 NK cells by NKG2D and 2B4.
We next assessed whether NF-kB activation requires cooperation
between coactivation receptors in pathophysiological contexts.
XLP1 is characterized by severe immunodeﬁciency resulting from
mutations in the SH2D1A gene encoding the SAP protein29–31.
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Given the requirement of SAP for 2B4-dependent NK cell
activation32,33, we hypothesized that NK cells from XLP1 patients
would demonstrate defects in NF-kB activation and NK cell
responses following coactivation. We ﬁrst tested the requirement
of SAP for NK cell activation during NKG2D and 2B4 synergy by
performing siRNA-mediated knockdown of SAP in NKL cells
(Supplementary Fig. 10a). The synergistic increases in Ca2þ
mobilization, NF-kB activation and IFN-g and MIP-1a release
were markedly diminished by SAP knockdown (Supplementary
Fig. 10b,c,d). Likewise, SAP knockdown markedly reduced the
synergistic increase in p65 phosphorylation and the proportion of
NK cells expressing IFN-g in primary NK cells following NKG2D
and 2B4 coactivation (Supplementary Fig. 11). The small increase
in IFN-g expression by ligating 2B4 but not NKG2D alone was
also selectively decreased by SAP knockdown.
Given these promising results, NK cells from XLP1 patients
were used to study the dependence of synergistic coactivation on
SAP expression. Among the four XLP1 patients examined, three
patients harboured macrodeletions in the SH2D1A gene that
resulted in complete loss of SAP expression, and one patient
harboured a missense mutation that reduced SAP expression, as
assessed by western blot analysis (Fig. 5a and Supplementary
Fig. 12). To probe the functional defects in XLP1 NK cells, we
measured target cell-induced degranulation, as determined by cell
surface expression of CD107a (ref. 28). Stimulation with K562 cell
line induced strong degranulation of both normal and XLP1 NK
cells (Fig. 5b,c). In contrast, XLP1 NK cells were severely
impaired in their ability to degranulate against Epstein–Barr virus
(EBV)-immortalized B-lymphoblastoid cell line 721.221 (referred
to as 221), an observation compatible with the defective killing of
EBV-infected B cells by XLP1 NK cells32.
Next, we tested whether SAP is required for NF-kB activation
and NK cell responses in XLP1 NK cells. Notably, the apparent
dual phosphorylation of p65 at serine 536 and 276 following
NKG2D and 2B4 coactivation seen in normal NK cells
was signiﬁcantly diminished in XLP1 NK cells (Fig. 5d).
The synergistic phosphorylation of Erk following coactivation
was also diminished in XLP1 NK cells, whereas Akt phos-
phorylation induced by NKG2D appeared to be unaffected.
In contrast, dual phosphorylation of p65 by CD16 ligation was
comparable in normal and XLP1 NK cells (Fig. 5d). Moreover,
NF-kB activation in XLP1 NK cells was measured by nuclear
translocation of p65 in individual NK-target cell conjugates.
A signiﬁcant defect in nuclear translocation of p65 following
coactivation was detected in XLP1 NK cells relative to normal NK
cells (Supplementary Fig. 13). Corroborating these ﬁndings, the
proportion of NK cells expressing IFN-g was severely decreased
in XLP1 NK cells following NKG2D and 2B4 coactivation, but
not CD16 (Fig. 5e,f). Most strikingly, the small increase in IFN-g
expression by 2B4 ligation was selectively defective in XLP1 NK
cells, consistent with a critical role of SAP in 2B4-mediated
signalling. A similar but less severe defect was observed
when degranulation was induced through 2B4 alone and in
combination with NKG2D, but not through CD16 (Fig. 6a,b).
These results did not appear to be associated with defective
expression of coactivation receptors in XLP1 NK cells, given
comparable expression of various activating receptors, including
NKG2D, 2B4 and CD16 (Fig. 6c). Instead, our results suggest that
the functional deﬁciencies in XLP1 NK cells by NKG2D and
2B4 coactivation are most likely due to selective defects in
2B4-associated synergistic signalling to Erk, which is important
for optimal NF-kB activation and effector functions.
Enhanced Vav1 signalling during NKG2D and 2B4
coactivation is required to overcome inhibition by c-Cbl and
deliver synergistic signals for NK cell activation4. Thus, we tested
whether aberrant Vav1 regulation is associated with such defects
seen in XLP1 NK cells. As reported, Vav1 phosphorylation was
induced in normal NK cells by engaging NKG2D or 2B4, and
was additive after co-engagement (Fig. 6d). Notably, Vav1
phosphorylation was impaired in XLP1 NK cells following 2B4
stimulation, but normal after NKG2D stimulation. Furthermore,
Vav1 phosphorylation after co-engaging NKG2D and 2B4 was
defective in XLP1 NK cells, similar to the level of phosphorylation
induced by NKG2D alone (Fig. 6d). Collectively, SAP deﬁciency
could cause a defect in 2B4, but not NKG2D, signalling at the
level of Vav1 and thereby impair the synergistic activation of Erk
and NF-kB following coactivation.
Vav1 is required for the synergistic activation of NF-jB. To
ensure that Vav1 is required for synergistic NF-kB activation,
we tested whether NF-kB activation following coactivation is
susceptible to Vav1 inhibition. Inhibitory signalling through
CD94-NKG2A can override Vav1-dependent activation of NK
cells4. The synergistic phosphorylation of p65 and Erk and the
combined phosphorylation of Vav1 induced by NKG2D and
2B4 coactivation were all abrogated by co-crosslinking CD94-
NKG2A on NKL cells (Fig. 7a). Moreover, NKG2D-dependent
phosphorylation of Akt, required for pS536-p65, was also
abrogated by the same inhibition. Accordingly, the synergistic
increase in transcriptional activity of NF-kB was markedly
impaired by co-crosslinking CD94-NKG2A (Fig. 7b). These
results suggest the suppression of NF-kB activation as a
mechanism underlying the inhibitory function of CD94-
NKG2A. To ascertain the direct involvement of Vav1 in NF-kB
activation, we performed siRNA-mediated knockdown of Vav1.
Similarly, Vav1 knockdown abrogated the phosphorylation of
p65, along with that of Akt and Erk, and in turn transcriptional
activity of NF-kB following coactivation (Fig. 7c,d). Collectively,
our results suggest that NF-kB activation in NK cells by NKG2D
and 2B4 coactivation is under the control of Vav1 and
dominantly inhibited by CD94-NKG2A.
Discussion
Here we offer a new perspective on the regulation of NF-kB
activation in NK cells during target cell recognition. NF-kB
activation via non-ITAM-associated receptors (for example,
NKG2D, 2B4, DNAM-1) relies on coordinated engagement of
coactivation receptors, which together provide complementary
and independent signals leading to optimal Vav1 and p65
phosphorylation (Fig. 8). The importance of such regulation
between Vav1 and p65 in NF-kB activation was supported by
signalling and functional defects centred on Vav1 in XLP1 NK
cells following coactivation.
A prevailing view of the mechanism underlying synergistic
coactivation involves signal integration by receptor-proximal
adaptor proteins that promote downstream signalling events for
cytokine production and target cell killing1. Supporting this, it
was shown that signals from synergizing receptors converge on
the adaptor protein SH2 domain-containing leukocyte
phosphoprotein of 76 kDa (SLP-76) through site-selective
phosphorylation of two tyrosines in SLP-76 (ref. 34). These two
phosphotyrosines enable simultaneous binding of Vav1-Nck
protein complex to both tyrosines on SLP-76, which leads to
Vav1-dependent synergistic signals. Vav1 is an essential
component for synergistic coactivation among combinations
of NKG2D, 2B4 and DNAM-1 (ref. 4). Thus, the dependence
of synergistic coactivation on the regulated interaction between
SLP-76 and Vav1 may represent a checkpoint in NK cell
activation that ensures proper speciﬁcity of NK cell responses.
Supporting this notion, the defective phosphorylation of Vav1 in
XLP1 NK cells, and the inhibition of Vav1 by inhibitory receptor
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or Vav1 knockdown resulted in abrogation of NF-kB activation
during coactivation.
In addition, our study revealed that Vav1-dependent
synergistic signalling was crucial but insufﬁcient for full NF-kB
activation. The outcome of NF-kB activation also relied on
signal integration by NF-kB p65 subunit via speciﬁc phos-
phorylation at regulatory serine residues. Post-translational
modiﬁcation of NF-kB subunit has long been appreciated as an
important regulatory mechanism, dictating its transcriptional
activity and target gene speciﬁcity25. Among others,
phosphorylation of the p65 subunit plays a key role in
determining the speciﬁcity, strength and duration of NF-kB-
dependent gene programmes24,27. Thus, such modiﬁcation likely
serves to ﬁne-tune NF-kB transcriptional activity, rather than
functions as a simple on-off switch27. Although the possibility of
signal integration by other proteins cannot be excluded, our
results reveal that synergistic NF-kB activation is kept in check at
the level of p65 by the requirement for a PI3K-Akt signal, in
addition to the Vav1-Erk signal. In a T-cell study, Akt was shown
to ﬁne-tune NF-kB signalling and transcription during CD3 and
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CD28 stimulation, in part through its effects on p65 (ref. 35). Of
interest, we observed that the requisite PI3K-Akt signal for
NF-kB activation was principally mediated by stimulation
through NKG2D or DNAM-1, but not 2B4. The natural ligands
for NKG2D (MICA/B and the family of ULBPs) and DNAM-1
(CD155 and CD112) are frequently upregulated on cells under
stress conditions associated with malignant transformation or
viral infection36,37. Thus, it is likely that NK cell stimulation by
NKG2D or DNAM-1 in combination with 2B4 could trigger
tailored NF-kB responses according to the expression levels of
cognate ligands on stressed cells.
The regulation of NF-kB activation at multiple levels may serve
as a safeguard to prevent inadvertent gene transcription. The
identiﬁcation of distinct signalling checkpoints ‘upstream’ at SLP-
76-Vav1 and ‘downstream’ at p65, as shown here, is consistent
with the tight control of NF-kB activation. Similar patterns of
SLP-76, Vav1 and p65 phosphorylation were induced by synergy
among NKG2D, 2B4 and DNAM-1, suggesting a common logic
for signal coordination among coactivation receptors. Moreover,
the dependence of synergistic p65 phosphorylation and NF-kB
activation on ‘upstream’ Vav1, and the defects of such regulation
in XLP1 NK cells, suggests that stepwise signalling checkpoints at
the level of Vav1 and p65 control NF-kB activation. Supporting
this, p65 phosphorylation at serine 536 by PI3K-Akt pathway
was apparent upon stimulation with NKG2D and 2B4, but not
NKG2D alone, although Akt phosphorylation by NKG2D
crosslinking was not enhanced by co-crosslinking with 2B4.
Likewise, in XLP1 NK cells, Vav1-dependent synergistic signal-
ling was prerequisite to mediate pS536-p65 by Akt pathway.
Our present analysis of XLP1 NK cells provides an insight into
the mechanism by which SAP deﬁciency affects NF-kB activation
and NK cell functions during coactivation. Mutations in the
SH2D1A gene, which result in the lack or dysfunction of SAP, form
the genetic basis of XLP1 (refs 29–31). XLP1 patients are
particularly susceptible to EBV infection. Among the defects in
XLP1 lymphocytes, the inability of XLP1 NK and CD8þ T cells to
eliminate EBV-infected B cells largely accounts for the persistence
of infected B cells, fulminant mononucleosis and B-cell
lymphoma38,39. SAP is an adaptor protein required for
transmitting activation signals elicited through SLAM family
receptors, including 2B4 (ref. 40). Accordingly, SAP-deﬁcient
XLP1 NK cells fail to be activated through 2B4 and show defects in
2B4-mediated killing of EBV-infected B cells and production of
IFN-g32,33. Here we found that SAP deﬁciency impedes synergistic
NF-kB activation by NKG2D and 2B4 coactivation at the level of
Vav1 and Vav1-dependent downstream signals, such as Erk. This
Erk pathway activation was required for cytotoxic degranulation
and crucial to phosphorylate p65 at key serine residue (S276-p65)
for NF-kB activation. These results are consistent with the
dependence of 2B4-mediated activation on SAP through Fyn-
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Figure 7 | Synergistic activation of NF-jB is Vav1-dependent. (a) Rested NKL cells were stimulated with NKG2D and/or 2B4 in combination with or
without CD94 engagement by receptor crosslinking. Lysates were immunoblotted for pS536-p65, pS276-p65, p65, p-Akt, p-Erk1/2, pY174-Vav1 or actin.
The normalized intensities of the phosphorylated p65 relative to p65 are presented. (b) Rested NKL-kB-GFP cells were stimulated with plate-immobilized
NKG2D and 2B4 in combination with or without CD94 for 6 h. GFP expression in the reporter NKL cells was analysed by ﬂow cytometry, and representative
result (left) and statistical bar charts (right) are shown. Values represent mean±s.d. (c) Rested NKL cells transfected with control siRNA or Vav1-speciﬁc
siRNA were stimulated with NKG2D and/or 2B4 by receptor crosslinking. Lysates were immunoblotted for pS536-p65, pS276-p65, p65, p-Akt, p-Erk1/2,
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ﬂow cytometry, and representative result (left) and statistical bar charts (right) are shown. Values represent mean±s.d. **Po0.01; ***Po0.001 (two-sided
Student’s t-test). Data are representative of at least three independent experiments.
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induced phosphorylation of Vav1 (ref. 8). However, possible
contribution of SAP deﬁciency to other transcription factors
including IRFs cannot be excluded. In SAP deﬁciency, 2B4 was
shown to recruit protein tyrosine phosphatases (for example,
SHIP-1) and impair the activity of co-engaged activating receptors
by delivering inhibitory signals8,30,32. A recent study showed that
this inhibitory function of 2B4 in XLP1 NK cells is conﬁned to
ITAM-dependent signalling pathways and does not affect the
activity of non-ITAM-associated NKG2D and DNAM-1 (ref. 41).
In support, upon NKG2D and 2B4 co-engagement, NKG2D-
dependent phosphorylation of Vav1 and Akt were preserved,
whereas synergistic signals through combined Vav1
phosphorylation were abrogated in XLP1 NK cells (Figs 5 and
6). In SAP-null murine NK cells, 2B4 could repress NKG2D42,
which, unlike human NKG2D, recruits both DAP10 and ITAM-
associated DAP12 (ref. 23). Thus, we speculate that 2B4-mediated
inhibition is selective to the activating receptors co-engaged,
although the exact mechanism underlying this selectivity in
inhibition remains to be determined.
It has been shown that NK cells become ‘primed’ upon exposure
to cytokines such as IL-2 or IL-15 and, in turn, have enhanced
reactivity against target cells, a situation that likely occurs during
the course of infection and transformation. Such cytokine-
stimulated NK cells respond to the engagement of single activating
receptor (for example, NKG2D, 2B4) for effector functions5,6,28,43,
probably due to a lower threshold for activation than resting NK
cells. Supporting this, the proportion of cells expressing IFN-g was
signiﬁcantly increased in IL-2 stimulated NK cells following
stimulation with NKG2D or 2B4 alone, correlating with
enhanced NF-kB activation (Supplementary Fig. 14a,b). Further,
IFN-g expression and NF-kB activation by NKG2D and 2B4
co-engagement were also enhanced after IL-2 stimulation,
suggesting that synergistic coactivation exists, even in the context
of a high IL-2 environment. We found a gradual decrease in c-Cbl
but not Vav1 and a marginal phosphorylation of Vav1 after IL-2
stimulation (Supplementary Fig. 14c,d), suggesting downregulation
of c-Cbl as a potential mechanism that relieves the requirement for
coactivation. However, the involvement of other regulatory
mechanism(s) cannot be excluded.
In conclusion, we provide evidence that, unlike ITAM-
dependent pathways, such as those triggered by antigen-speciﬁc
receptors of adaptive immune cells and Fcg receptor CD16 in NK
cells, a single coactivation receptor such as 2B4 or NKG2D is
incompetent to induce NF-kB activation. Instead, it requires
complementation of coactivation receptors with distinct signal-
ling properties to achieve proper speciﬁcity and optimal
magnitude of NF-kB activation. Because PI3K-Akt and Erk
pathways are often induced by diverse NF-kB-activating
stimuli26,27 and involved in site-selective phosphorylation of
p65, the model for coordinated NF-kB activation through
combined p65 phosphorylation described here may apply to
other NF-kB-activating stimuli in various cell types.
Methods
Cells and reagents. Human blood samples from normal healthy donors and XLP1
donors were drawn for research purposes under a protocol approved by the
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institutional review board with informed consent. Patients with a conﬁrmed
SH2D1A gene mutation were included. Peripheral blood mononuclear cells
(PBMCs) were isolated from the blood samples by density gradient centrifugation
(LSM lymphocyte separation medium; MP Biomedicals) and cryopreserved until
processed. Human NK cells were puriﬁed from PBMCs by negative selection using
the NK cell isolation kit (StemCell Technologies). These cells were 97–99%
CD3-CD56þ , as assessed by ﬂow cytometry. The human NK cell line NKL
(gift from M. Robertson) was cultured in RPMI-1640 supplemented with 10% FBS,
1mM sodium pyruvate and 200Uml 1 recombinant IL-2 (rIL-2). NKL cells were
rested in RPMI-1640 supplemented with 5% FBS and 0.5mM sodium pyruvate
without rIL-2 for 24 h. P815 cells (American Type Culture Collection) were
cultured in IMDM (Cellgro) supplemented with 10% FBS and 2mM L-glutamine.
P815 cells are FcRþ and, upon incubation with antibodies (Abs) to NK
cell-activating receptors (for example, NKG2D and 2B4), bind the Abs via the Fc-
region. In doing so, they can activate NK cells through speciﬁc activating receptors
in direct cell–cell contact. 721.221 cells (221; gift of J. Gumperz and P. Parham) and
K562 cells (American Type Culture Collection) were maintained in IMDM
(Cellgro) supplemented with 10% FBS. K562 cells are of the erythroleukemia type
and known to express ligands for NKG2D, DNAM-1 and NKp30 receptors44,45.
221 cells are an EBV-transformed B cell line, and their lysis by NK cells is
associated with 2B4, NKp44 and NKp46 receptors32,46. K562 and 221 cells were
used to validate the functional defects of XLP1 NK cells, given an impaired
susceptibility of 221 cells to XLP1 NK cells likely due to the involvement of 2B4 in
mediating lysis of the cells. K562-mb15-41BBL cell line (gift of D. Campana) for
NK cell expansion were cultured in RPMI-1640 supplemented with 10% FBS.
Expression of human ligands for NK cell receptor in P815 cells has been
described47. 293T cells were cultured in DMEM (Cellgro) supplemented with 10%
FBS and 2mM GlutaMAX (Gibco). The cells were free of mycoplasma
contamination. All chemicals were from Calbiochem unless indicated otherwise.
Patient samples. Four patients with a conﬁrmed mutation in the SH2D1A gene
were included in this study. XLP1 patient samples (patients 1 and 2) were provided
by Dr Booth48. Patient samples 3 and 4 were obtained from Dr Nichols49. Both
patients 1 and 2 had macrodeletions in the SH2D1A gene. Patient 3 exhibited a T53I
missense mutation in the SH2D1A protein and patient 4 had a germline deletion in
the SH2D1A gene. The expression of SAP protein was absent in the NK cells obtained
from three patients (patients 1, 2 and 4) and very low in patient 30s NK cells.
Abs. Abs for NK cell receptors and signalling molecules were obtained from the
following sources: NKG2D (149810; R&D Systems); CD244/2B4 (C1.7; Beckman
Coulter); isotype control mouse IgG1 (MOPC-21; Sigma); CD226/DNAM-1
(DX11), CD16 (3G8), CD94 (HP-3D9), pS32/36 IkBa (39A1413) and actin (C4)
(BD Biosciences); pY174 Vav1 (ab47282) and pS276 p65 (ab30623; Abcam); Vav1
(H211), p65 (F-6), p50 (H-119), SAP (1D12) and IkBa (C-21; Santa Cruz);
a-tubulin (GT114; GeneTex); Vav1 (R775), pS536 p65 (93H1), pS176/180 IKKa/b
(16A6), pS473 Akt (9271), pY202/204 Erk1/2 (9101) and TBP (44059; Cell
Signaling); c-Cbl (7G10) and T7 (AB3790; Millipore). Goat F(ab0)2 anti-mouse IgG
was obtained from Jackson ImmunoResearch. The ﬂuorochrome-conjugated Abs
were used in the ﬂow cytometric analyses: a-pS536 p65-Alexa Fluor 488 (93H1)
and isotype control rabbit IgG-Alexa Fluor 488 (DA1E; Cell Signaling); a-CD3-
PerCP (SK7), a-CD56-PE (NCAM16.2), a-CD107a-FITC (H4A3), a-IFN-g-FITC
(25723.11), a-CD16-PE (3G8), a-CD336/NKp44-PE (p44-8.1), a-NKp46-PE
(9E2), a-CD226/DNAM-1-PE (DX11) and a-CD48-PE (TU¨145; BD Bioscience);
a-TNF-a-FITC (MAb11, eBioscience); a-CD244/2B4-PE (C1.7) and a-NKp30-PE
(Z25; Beckman Coulter); a-NKG2D-PE (149810), a-NKG2C-PE (134591) and
a-ULBP1-PE (170818; R&D Systems). CFSE, a-mouse IgG-Biotin and Alexa Fluor
647-Streptavidin were obtained from Invitrogen for use in confocal microscopy.
Mouse Fc block was done with anti-Fcg RII/III (2.4G2; BD Bioscience).
Cellular assays. IFN-g (Pierce) and MIP-1a (R&D Systems) production after
stimulation of cells with beads coated with monoclonal antibodies (mAbs) to NK
receptors were determined by ELISA. Brieﬂy, beads for NK cell stimulation were
prepared by incubating goat anti-mouse-coated beads (4 107; Dynabeads M-450)
with the indicated mAbs (3 mg) in PBS containing 2% FBS for 1 h at 4 C. After
washing three times in PBS, 2% FBS, the beads (4 107) were incubated with
rested NKL cells (4 107) in 500 mL IMDM, 10% FBS for the indicated times at
37 C. The cultures were rotated end-over-end during the stimulation, after which
the supernatants were assayed.
Intracellular Ca2þ mobilization was measured by ﬂow cytometry in cells
labelled with Fluo-4 AM (Invitrogen) as described34. Brieﬂy, NK cells were labelled
for 30min at 30 C with dye-loading buffer (Hanks’ balanced salt solution (HBSS)
with 1% FBS, 2 mM Fluo-4 AM and 4mM probenecid). Cells were then washed
twice, resuspended in HBSS, 1% FBS and incubated with the indicated mAbs
(10 mgml 1) for 30min on ice. Cells were washed twice and resuspended in HBSS
containing 1% FBS, and transferred to ﬂow cytometry analysis tubes. Cells were
warmed for 5min at 37 in a water bath, and placed on the ﬂow cytometer. After
30 s of data acquisition, tubes were removed, and 4 mg of cross-linking goat
anti-mouse F(ab0)2 was added. Cells were mixed by vortexing, placed back on the
ﬂow cytometer (BD Bioscience) and events were acquired for a further 5min. Data
were analysed with FlowJo software (Tree Star).
Degranulation of NK cells was assessed by CD107a expression on the cell
surface and granzyme B release (BioLegend) as described28. Brieﬂy, primary rested
NK cells were mixed with an equal number of K562 or 221 cells in the presence of
anti-CD107a-FITC mAbs, spun down for 3min at 30g, incubated for 2 h at 37 C,
and spun down again. The cell pellets were resuspended in FACS buffer (PBS
with 2% FBS) and stained with anti-CD56-PE for 30min in the dark at 4 C.
Lymphocytes were gated on forward scatter/side scatter, and the CD107a
expression on NK cells was analysed by ﬂow cytometry and FlowJo software. For
granzyme B release assay, rested NKL cells after transfection with control siRNA or
p65-speciﬁc siRNA were stimulated with plate-immobilized mAbs to NKG2D and/
or 2B4 for 2 h. Thereafter, granzyme B release into the supernatants were
determined by ELISA.
Cytokine production by primary NK cells was determined by the intracellular
expression of IFN-g and TNF-a as described14. PBMCs or primary rested NK cells
were stimulated with an equal number of the indicated target cells for 1 h at 37 C.
Thereafter, brefeldin A (GolgiPlug; BD Bioscience) was added, followed by an
additional 5 h of incubation for a total of 6 h. The cells were then stained for surface
markers with anti-CD56-PE and/or anti-CD3-PerCP mAbs for 30min in the dark
at 4 C. After washing the cells twice with FACS buffer, they were incubated in BD
Cytoﬁx/Cytoperm solution (BD Bioscience) for 20min in the dark at 4 C. Before
and after intracellular staining with anti-IFN-g-FITC or anti-TNF-a-FITC mAb for
30min in the dark at 4 C, the cells were washed twice with BD Perm/Wash buffer
(BD Bioscience). The cells were then analysed by ﬂow cytometry gated on NK cells.
Receptor crosslinking and cell mixing experiments. For Ab-mediated cross-
linking of NK receptors, NK cells were preincubated with isotype control mAb or
mAbs speciﬁc for NK receptors (all at 10mgml 1) for 30min on ice. After washing
unbound Abs with medium, NK cells were stimulated by crosslinking with
30mgml 1 goat anti-mouse F(ab0)2 secondary Ab at 37 C for the indicated times.
For stimulation of NK receptors mediated by plate-immobilized Abs, 96-well Costar
EIA/RIA Stripwell plates were coated overnight at 4 C with isotype control mAb or
mAbs speciﬁc for NK receptors (all at 10mgml 1). Then, NK cells were added into
NK receptor mAb-coated plates for the indicated times. For cell mixing experiments,
NK and P815 target cells separately chilled on ice were mixed at an effector to target
ratio of 1:1. Cells were incubated for 10min on ice and then incubated at 37 C for
the indicated times. Cells were moved to ice and then lysed for further analysis.
Assessment of NF-jB activation by electrophoretic mobility shift assay (EMSA).
Nuclear and cytoplasmic fractions were isolated from stimulated and unstimulated
NKL cells using Nuclear Extract kit (Active Motif) according to the manufacturer’s
protocol. The amount of p65 in nuclear fraction and its DNA-binding activity were
measured by an immunoblotting and TransAM NF-kB p65 ELISA kit (Active Motif)
following the manufacturer’s instruction, respectively.
NF-jB reporter assay. NKL reporter cells (NKL-kB-GFP) that express GFP under
the control of NF-kB transcription response elements were generated by transducing
NKL cells with lentiviral kB-GFP construct (System Biosciences). Lentiviral particles
were produced by simultaneous transfection of 293TN packaging cell line (System
Biosciences) with pGreenFire-NF-kB-EF1-Puro vector and pPACKH1 packaging
plasmid mix (System Biosciences). NKL cells were transduced with lentivirus
supernatant that encodes kB-GFP in the presence of 10mgml 1 polybrene and
200Uml 1 rIL-2 and then selected with 1mg ml 1 puromycin (2 days after
transduction). Thereafter, NKL transductants showing GFP upregulation upon
TNF-a treatment were further selected by FACS-sorting and grown as pure cultures.
To assess NF-kB activation, NKL-kB-GFP cells were stimulated with TNF-a or
plate-immobilized mAbs speciﬁc for NK receptors, and GFP expression in the
reporter NKL cells was analysed by ﬂow cytometry.
RNA interference. NKL cells were transfected with 300 pmol of siRNA with the
Amaxa Nucleofector II system. A total of 1.2 106 cells were resuspended in 100ml
of Amaxa kit solution V (Lonza), mixed with siRNA and immediately transfected
with programme O-017. For a total of 48 h incubation at 37 C, cells were rested for
the last 24 h and then assayed as indicated. For knockdown in primary NK cells,
1.5 106 expanded cells were resuspended in 100ml of Amaxa kit solution for
human macrophage, mixed with 300 pmol of siRNA and transfected with pro-
gramme X-001. Thereafter, cells were incubated for 36 h in the presence of IL-2
(200Uml 1), rested for 12 h and then assayed as indicated. The siRNAs speciﬁc
for NF-kB p65 were part of TriFECTa Dicer-substrate kit obtained from Integrated
DNA Technologies (IDT) and the following siRNA sequences were used: p65,
50-GGAGUACCCUGAGGCUAUAACUCGC-30 (sense) and 50-GCGAGUUAU
AGCCUCAGGGUACUCCAU-30 (antisense) or 50-GGACAUAUGAGACCUUC
AAGAGCAT-30 (sense) and 50-AUGCUCUUGAAGGUCUCAUAUGUCCUU-30
(antisense). The siRNAs used to knockdown of Vav1 and c-Cbl were described
previously4 and the sequences are as follows: Vav1, 50-CGUCGAGGUCAAGC
ACAUUdTdT-30 (sense) and 50-AAUGUGCUUGACCUCGACGdTdT-30
(antisense); c-Cbl: 50-CCUCUCUUCCAAGCACUGAdTdT-30 (sense) and 50-UC
AGUGCUUGGAAGAGAGGdTdT-30 (antisense). ON-TARGETplus SMARTpool
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siRNAs speciﬁc for Vav1 (L-003935), c-Cbl (L-003003) were also obtained from
Dharmacon. The siRNA speciﬁc for SAP were obtained from IDT and the
sequences are as follows: SAP, 50-GCUGUAUCACGGUUACAUUUAUACA-30
(sense) and 50-UGUAUAAAUGUAACCGUGAUACAGCAC-30 (antisense).
siRNA speciﬁc for SAP (SI00036561) were also obtained from Qiagen.
ON-TARGETplus SMARTpool siRNAs speciﬁc for Akt1 (L-003000) or Erk2
(L-003555) were obtained from Dharmacon. A second set of siRNAs for Akt1 and
Erk2 was used, with the following sequences: Akt1, 50-GGACAGAGGAGCA
AGGUUUdTdT-30 (sense) and 50-AAACCUUGCUCCUCUGUCCdTdT-30
(antisense); Erk2: 50-GGGUUCCUGACAGAAUAUGdTdT-30 (sense) and 50-CAU
AUUCUGUCAGGAACCCdTdT-30 (antisense). Similar results were obtained with
either one of the siRNAs used. The results shown in this paper are those obtained
with the former set of siRNA oligonucelotides. The negative siRNA controls were
obtained from IDT and Dharmacon.
Ex vivo expansion of NK cells. Owing to the limited supply of patient NK cells,
NK cells from XLP1 patients were expanded to study molecular signals for NF-kB
activation and effector functions. NK cells from normal donors were also expanded
and, after a period of rest, reproduced the synergistic increase in effector functions
and signalling following stimulation with NKG2D and 2B4. Primary NK cells
obtained from normal or XLP1 donors were expanded by stimulation with the
K562-mb15-41BBL cell line, as previously described50,51 with slight modiﬁcations.
1.5 106 PBMCs were cultured with 1 106 100Gy gamma ray-irradiated
K562-mb15-41BBL feeder cells in stem cell growth medium (CellGenix)
supplemented with 10% FBS and 10Uml 1 rIL-2. The medium was changed
every 2 days and replaced with fresh medium containing 10Uml 1 rIL-2. After 1
week of coculture, residual T cells were depleted using the CD3þ selection kit
(StemCell Technologies). The remaining cells were further expanded for an
additional 2 weeks in stem cell growth medium supplemented with 10% FBS,
100Uml 1 rIL-2 and 5 ngml 1 rIL-15. The resulting cell population was 97–99%
CD3-CD56þ , as assessed using ﬂow cytometry.
DNA constructs and transfections. Given a difﬁculty in detecting p65 phos-
phorylation at serine 276 (ref. 52), the speciﬁcity of the antibody against pS276 p65
(ab30623) was conﬁrmed (Supplementary Fig. 15). The plasmids encoding T7-RelA
(#21984) or T7-RelA S276A (#24153) were obtained from Addgene and veriﬁed by
sequencing. 0.5 106 293T cells were cultured for 18 h and then transfected with
2mg of plasmid DNA using X-tremeGENE 9 (Roche). Medium was changed after
24 h post-transfection and transfected cells were assayed after another 24 h.
Immunoblotting. The stimulated NK cells were washed with ice-cold PBS and lysed
in lysis buffer (50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% Triton X-100, 5mM
EDTA, 1mM NaVO3, 50mM NaF, 1mM phenylmethylsulfonyl ﬂuoride (PMSF)
and protease inhibitor cocktail (Thermo)) for 30min on ice. Cell debris, including
the nuclei, was removed by centrifugation, and the supernatants were recovered. The
protein concentration of the cell lysates was determined using the BCA protein
assay kit (Pierce). Lysates were resuspended in 1 NuPAGE LDS sample buffer
(Invitrogen) containing 50mM dithiothreitol, and further incubated for 10min at
70 C. Equal amounts of protein for each sample were resolved on 8% Tris-HCl gel
or 4–20% Tris-HEPES gel (Thermo) and subsequently transferred onto PVDF
membranes (Millipore) in transfer buffer (25mM Tris, 192mM glycine, 20% (v/v)
methanol). The membranes were blocked with 5% BSA or skim milk in TBS-T
(Tris-buffered saline containing 0.1% Tween-20) for 1 h and subsequently incubated
with primary Abs and then with the HRP-conjugated secondary Abs. Blots were
developed using SuperSignal West Pico and detected using LAS-4000 (Fujiﬁlm).
Images have been cropped for presentation. Full-size images are presented in
Supplementary Fig. 16.
Cell conjugation and immunoﬂuorescence. To examine NF-kB p65 translocation
into the nucleus in the individual NKL cells that were conjugated with target cells,
NKL cells were ﬁrst stained with 10mM CFSE (Invitrogen) for 15min at 37 C,
washed and resuspended in IMDM supplemented with 5% FBS. P815 cells were
incubated with 10mg ml 1 isotype control mAb or mAbs speciﬁc to NK receptors
for 20min at room temperature (RT), spun down and resuspended in IMDM
containing 5% FBS. Thereafter, CFSE-loaded NKL cells were conjugated to the P815
target cells at a 2:1 E/T ratio for 30min at 37 C and then allowed to adhere to poly-
L-lysine-coated slide glass (Sigma) for 15min at 37 C. Slides were ﬁxed in 4%
paraformaldehyde (Electron Microscopy Sciences) for 30min at RT and in cold
methanol for 10min at  20 C. The cells were then permeabilized with 0.1% Triton
X-100 (Sigma) and 0.1% sodium citrate (Sigma) in PBS for 3min at 4 C and blocked
with PBS containing 1% BSA and 1% goat serum for 30min. Slides were incubated
with primary Ab to p65 (1:100, F-6; Santa Cruz) for 90min, a-mouse IgG-Biotin
(1:100; Invitrogen) for 40min, Alexa Fluor 647-Streptavidin (1:50; Invitrogen) for
30min in PBS containing 1% BSA and 0.5% Triton X-100, and then 4,6-diamidino-
2-phenylindole (300nM; Molecular Probes) for 2min. All slides were incubated at
RT and washed three times with PBS. The slides were mounted with ProLong Gold
antifade reagent (Molecular Probes) and 0.13–0.16mm coverslips (Marienfeld). The
cells were imaged using the Zeiss LSM710 laser-scanning Confocal Microscope
(Carl Zeiss) and analysed using the MetaMorph software (Molecular Devices).
NKL-target cell conjugates were veriﬁed by the presence of a CFSE-stained cell that
had conjugated to an unstained cell.
Real-time PCR. To assess the expression of genes related to NK cell effector
functions, total RNA was isolated using the RNeasy kit (QIAGEN). cDNA was
synthesized from 1 mg RNA using the ReverTra Ace qPCR RT kit (Toyobo)
according to the manufacturer’s instructions. Real-time PCR ampliﬁcation and
analysis were conducted using the SYBR Green Realtime PCR Master Mix
(Toyobo) and LightCycler 480 Real-Time PCR System (Roche Diagnostics). The
PCR conditions were as follows: preheating for 10min at 95 C, 40 cycles of 95 C
(30 s), 60 C (30 s) and 72 C (30 s). Melting curve analysis was done using the
default settings of the device. RNA levels were normalized to b-actin expression
using the DDCt method. Primer sequences for real-time PCR are described in the
Supplementary Table 1.
Flow cytometric analysis of p65 phosphorylation. Puriﬁed human primary NK
or NKL cells were incubated with isotype control mAb or mAbs speciﬁc to NK
receptors on ice for 30min. After being washed with medium, NK cells were
stimulated by receptor cross-linking with goat anti-mouse F(ab0)2 secondary Ab at
37 C for 5min. The cells were washed with DPBS and ﬁxed with 4% paraf-
ormaldehyde at 37 C for 10min. The ﬁxed cells were then permeabilized with 90%
methanol on ice for 30min and blocked with 0.5% BSA at RT for 10min. Cells
were analysed for p65 phosphorylation using ﬂow cytometry after staining with
Alexa Fluor 488-conjugated anti-pS536 p65 Ab (93H1) or isotype control rabbit
IgG (DA1E; Cell Signaling).
Statistical analyses. Each graph was generated from at least three independent
experiments. Results are presented as the mean±s.d. or s.e.m. Statistical analyses
were conducted by two-tailed Student’s t-test using the GraphPad Prism software.
Data availability. The data that support the ﬁndings of this study using patient
samples are available on request from the corresponding author H.S.K. The data
are not publicly available due to them containing information that could com-
promise research participant privacy/consent.
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